natgillin/translations-raw huggingface dataset:
A clinical trial in a single intensive care unit treating hyperglycaemia (blood glucose above 10 mmol/l) in 204 diabetic and 1344 non-diabetic patients undergoing major surgery showed that normoglycaemia (blood glucose 4.4 - 6.1 mmol/l) induced by intravenous treatment with another fast acting human insulin (Actrapid) reduced mortality by 42% (8% versus 4.6%).
Klini no preskušanje zdravljenja hiperglikemije (glukoza v krvi nad 10 mmol/l) v eni sami intenzivni enoti pri 204 diabeti nih in 1344 nediabeti nih bolnikih po ve ji operaciji je pokazala, da je normoglikemija (glukoza v krvi 4,4-6,1 mmol/l), dosežena z intravenskim zdravljenjem z drugim hitrodelujo im humanim insulinom (Actrapid), zmanjšala umrljivost za 42 % (8 % v primerjavi s
The pharmacokinetic profile has been studied in a small number (n=18) of diabetic children (aged 612 years) and adolescents (aged 13-17 years) using another fast-acting human insulin, (Actrapid).
Farmakokineti ni profil zdravila Velosulin je bil raziskan pri majhnem številu (n = 18) diabeti nih otrok (starost 6-12 let) in mladostnikov (starost 13-17 let)., ki so uporabljali drug hitro delujo insulin (Actrapid).
• Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
• Hude hipoglikemije, ko je bolnik nezavesten, je mogo e zdraviti z glukagonom (0,5 do 1 mg), ki ga da ustrezno podu ena oseba intramuskularno ali subkutano ali z glukozo, ki jo da zdravstveni delavec intravensko.
Use only catheters where the material in contact with the insulin is made of polyethylene or polypropylene.
Uporabljajte le katetre, v katerih je material, ki je v stiku z insulinom, iz polietilena ali polipropilena.
Very rare - Diabetic retinopathy
Zelo redki - diabeti na retinopatija
Velosulin is accompanied by a package leaflet with detailed instruction for use to be followed.
Zdravilu Velosulin je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
Patients should be advised to take precautions to avoid hypoglycaemia whilst driving.
Bolnikom je treba svetovati, naj upoštevajo ustrezne previdnostne ukrepe, da bi se izognili hipoglikemiji med upravljanjem vozila.
Inadequate dosage or discontinuation of treatment, especially in type 1 diabetes, may lead to hyperglycaemia.
Neustrezno odmerjanje ali prekinitev zdravljenja lahko, zlasti pri diabetesu tipa 1, povzro i hiperglikemijo.
Continuous subcutaneous infusion eliminates some of the variations/fluctuations inherent to injection therapy.
Stalno subkutano infundiranje odpravi nekatere spremembe/nihanja, povezane z injekcijskim zdravljenjem.
This is part of a multipack and not for sale of individual vials
To je del pakiranja z ve vialami in ni namenjen za prodajo posameznih vial.
If your doctor has switched you from one type or brand of insulin to another, your dose may have to be adjusted by your doctor.
e vam zdravnik eno vrsto ali znamko insulina zamenja z drugo, vam bo morda moral prilagoditi odmerek.
If you don't treat it, this could lead to diabetic coma and death.
e ga ne zdravite, lahko povzro i diabeti no komo in smrt.
In general, when patients are transferred from injection to infusion therapy, it may be advisable to reduce the dosage by initiating the patient at 90% of the previous total daily dosage, with 40% as basal rate and 50% as boluses divided between the three main meals.
Na splošno utegne biti pri bolnikih, ki prehajajo z injekcijskega zdravljenja na zdravljenje z infuzijo, priporo ljivo zmanjšati odmerek, tako da bolnik za ne z 90 % prejšnjega celotnega dnevnega odmerka, in sicer s 40 % kot bazalna infuzija in 50 % kot bolusi, razdeljenimi med tri glavne obroke.
- If you have any further questions, ask your doctor, diabetes nurse or your pharmacist.
- e imate dodatna vprašanja, se posvetujte z zdravnikom, diabetološko sestro ali farmacevtom.
Pharmacotherapeutic group: insulins and analogues for injection, fast-acting, insulin (human).
Farmakoterapevtska skupina: insulini in analogi za injiciranje, s hitrim delovanjem, humani insulin.
To get the benefit of insulin infusion, and to detect possible malfunction of the pump, the patient should measure his blood glucose level regularly.
Da bi infuzija insulina koristila in da bi odkril morebitno nepravilno delovanje rpalke, mora bolnik redno meriti koncentracijo glukoze v krvi.
The following substances may reduce insulin requirement:
Potrebo po insulinu lahko zmanjšajo naslednje snovi:
A few patients who have experienced hypoglycaemic reactions after transfer from animal source insulin have reported that early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin.
Maloštevilni bolniki, ki so po prehodu z insulina živalskega izvora doživeli hipoglikemije, so navedli, da so bili zgodnji opozorilni simptomi hipoglikemije manj izraziti ali so se razlikovali od tistih, ki so jih doživeli s prejšnjim insulinom.
When you first start your treatment, it may disturb your vision, but the reaction usually disappears.
Ko za nete prvi uporabljati zdravilo, lahko povzro i motnje vida, ki pa ponavadi izginejo.
When Velosulin is administered as a bolus injection onset of action is within ½ hour, reaches a maximum effect within 1.5-3.5 hours and the entire duration of action is approximately 7-8 hours.
e je Velosulin uporabljen v bolusni injekciji, za ne delovati v ½ ure, doseže najve ji u inek v 1,53,5 urah in ima celotni as delovanja približno 7-8 ur.
Use only syringes made of polyethylene, polypropylene or glass.
Uporabljajte samo brizge iz polietilena, polipropilena ali stekla.
Continuous rotation of the injection site within a given area may help to reduce or prevent these reactions.
Stalno krožno menjavanje mest injiciranja na posameznem predelu pomaga zmanjšati ali prepre iti te reakcije.
Painful neuropathy (nerve related pain).
Bole a nevropatija (z živci povezana bole ina).
You may recover more quickly from unconsciousness with an injection of the hormone glucagon by someone who knows how to use it.
Iz nezavesti se boste morda zbudili prej, e dobite injekcijo hormona glukagona; dati jo mora oseba, ki ga zna uporabljati.
Using glucagon
Uporaba glukagona
Talk to your doctor or pharmacist if you take or have recently taken any other medicines, even those not prescribed.
Posvetujte se z zdravnikom, e jemljete ali ste jemali katero koli drugo zdravilo, tudi e ste ga dobili brez recepta.
Your blood sugar may get too high (this is called hyperglycaemia).
Sladkor v krvi se vam lahko preve zviša (to imenujemo hiperglikemija).
QUALITATIVE AND QUANTITATIVE COMPOSITION Insulin human, rDNA (produced by recombinant DNA technology in Saccharomyces cerevisiae).
Humani insulin, rDNA (pridobljen s tehnologijo rekombinantne DNA iz Saccharomyces cerevisiae).
Velosulin should not be disposed of via wastewater or household waste.
Zdravila Velosulin ne smete odvre i v odpadne vode ali med gospodinjske odpadke.
The daily insulin requirement may be higher in patients with insulin resistance (e.g. during puberty or due to obesity) and lower in patients with residual, endogenous insulin production.
Dnevna potreba po insulinu je lahko ve ja pri bolnikih z odpornostjo proti insulinu (npr. med puberteto pri mladih ali zaradi debelosti) in manjša pri bolnikih z rezidualnim endogenim nastajanjem insulina.
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON Medicinal product subject to medical prescription
• POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE, PREDPISANI IMETNIKU
Use only teflon-coated or stainless steel needles.
Uporabljajte le s teflonom prekrite igle ali igle iz nerjave ega jekla.
An injection or infusion should be followed within 30 minutes by a meal or snack containing carbohydrates.
Injekciji ali infuziji insulina mora po 30 minutah slediti obrok ali prigrizek, ki vsebuje ogljikove hidrate.
INFORMATION IN BRAILLE Velosulin
PODATKI V BRAILLOVI PISAVI Velosulin
This leaflet is a general guide.
To navodilo za uporabo obsega splošna navodila.
In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved.
V primeru hipoglikemije je treba infuzijo ustaviti, dokler hipoglikemija ne mine.
The relatively fast absorption of soluble insulin ensures a constant supply of insulin to the blood from a relatively small pool under the skin.
Razmeroma hitra absorpcija topnega insulina zagotavlja stalen dotok insulina v kri iz razmeroma majhne koli ine pod kožo.
After delivery, insulin requirements return rapidly to pre-pregnancy values.
Po porodu se potreba po insulinu hitro vrne na vrednosti pred nose nostjo.
Your insulin will work more quickly if you inject it around the waist.
Insulin bo deloval hitreje, e ga injicirate v predelu trebuha.
See the advice in 4 What to do in an emergency.
Glejte nasvet v poglavju 4.
Velosulin is for injection under the skin (subcutaneously).
Velosulin je namenjen injiciranju pod kožo (subkutani uporabi).
These symptoms are usually of transitory nature.
Ponavadi so prehodne.
Causes of hyperglycaemia
Vzroki za hiperglikemijo
Diabetic retinopathy (eye background changes).
Diabeti na retinopatija (spremembe na o esnem ozadju).
If your blood sugar gets too high
e se vam sladkor v krvi preve zviša
1 vial contains 10 ml equivalent to 1000 IU.
1 viala vsebuje 10 ml, kar ustreza 1000 i.e.
Administration For subcutaneous or intravenous use.
Za subkutano ali intravensko uporabo.
Read and follow carefully the instructions that accompany your insulin pump.
Preberite in natan no upoštevajte navodila, priložena vaši insulinski rpalki.
Dosage adjustment may be necessary when transferring patients from one insulin preparation to another (see section 4.4 ).
Pri prehodu bolnikov z enega insulinskega pripravka na drugega utegne biti potrebna prilagoditev odmerjanja (glejte poglavje 4.4).
Velosulin may cause hypoglycaemia (low blood sugar).
Velosulin lahko povzro i hipoglikemijo (nizek krvni sladkor).
On rare occasions, injection site reactions may require discontinuation of Velosulin.
V redkih primerih utegne biti zaradi reakcij na mestu injiciranja potrebna prekinitev uporabe zdravila Velosulin.
Concomitant illness, especially infections and feverish conditions, usually increases the patient's insulin requirement.
Spremljajo e bolezni, posebno okužbe in stanja z zvišano telesno temperaturo, ponavadi zve ajo bolnikovo potrebo po insulinu.
A specific overdose of insulin cannot be defined.
Specifi nega prevelikega odmerjanja insulina ni mogo e definirati.
If it isn't in perfect condition when you get the vial, return the vial to your supplier If it hasn't been stored correctly or been frozen (see 6 How to store Velosulin) If it does not appear water clear and colourless.
e ta tedaj, ko dobite vialo, ni v povsem brezhibnem stanju, vialo vrnite e ni bilo shranjeno pravilno ali je zmrznilo (glejte poglavje 6.
It is recommended that you measure your blood glucose regularly.
Priporo ljivo je, da si redno merite glukozo v krvi.
The vial may be kept at room temperature (not above 25°C) for 6 weeks after first opening.
Vialo lahko shranjujete pri sobni temperaturi (do 25 °C) 6 tednov po prvem odprtju.
If you have diabetic retinopathy and your blood glucose levels improve very fast, the retinopathy may get worse.
e imate diabeti no retinopatijo in se vam koncentracija sladkorja v krvi zelo hitro izboljša, se retinopatija lahko poslabša.
This is a multipack and not for sale of individual vials
To je pakiranje z ve vialami in ni namenjeno za prodajo posameznih vial.
Fast improvement in blood glucose control may be associated with a condition termed “acute painful neuropathy”, which is usually reversible.
Hitro izboljšanje urejenosti glukoze v krvi lahko spremlja motnja, imenovana ˝akutna bole a nevropatija˝, ki je ponavadi reverzibilna.
Use in infusion pump
Uporaba v infuzijski rpalki
Dosage is individual and determined in accordance with the needs of the patient.
Odmerjanje je individualno in dolo eno skladno z bolnikovimi potrebami.
Reactions (redness, swelling, itching) at the injection site may occur (local allergic reactions).
Pojavijo se lahko reakcije (pordelost, oteklina, srbenje) na mestu injiciranja (lokalne alergijske reakcije).
Clear, colourless, aqueous solution.
Bistra, brezbarvna, vodna raztopina.
The terminal half-life (t½) is therefore a measure of the absorption rather than of the elimination per se of insulin from plasma (insulin in the blood stream has a t½ of a few minutes).
Terminalni razpolovni as (t1/2) je torej merilo absorpcije, ne izlo anja insulina iz plazme per se (insulin v krvnem obtoku ima t1/2 nekaj minut).
Injection sites should be rotated within an anatomic region in order to avoid lipodystrophy.
Mesta injiciranja je treba znotraj anatomskega predela krožno menjavati, da bi se izognili lipodistrofiji.
As for other insulin products, in general, hypoglycaemia is the most frequently occurring undesirable effect.
Tako kot pri drugih insulinih je praviloma najpogostejši neželeni u inek hipoglikemija.
Dosage is individual and determined by the physician in accordance with the needs of the patient.
Odmerjanje je individualno in ga dolo i zdravnik skladno z bolnikovimi potrebami.
Side effects reported uncommonly (in less than 1 patient in 100)
Ob asno opisani neželeni u inki (pri manj kot 1 bolniku na 100)
There are no restrictions on treatment of diabetes with insulin during pregnancy, as insulin does not pass the placental barrier.
Omejitev za zdravljenje diabetesa z insulinom med nose nostjo ni, ker insulin ne prehaja placentne pregrade.
Velosulin is a fast-acting insulin.
Velosulin je hitrodelujo i insulin.
Insulin solutions should not be used if they do not appear water clear and colourless.
Raztopin insulina se ne sme uporabiti, e niso bistre kot voda in brezbarvne.
Not all packs may be marketed.
Na trgu ni vseh navedenih pakiranj.
If you drive or use tools or machines: watch out for signs of a hypo.
Vpliv na sposobnost upravljanja vozil in strojev e vozite ali uporabljate orodja ali stroje: pazite na znake hipe.
If repeated or severe low blood glucose levels occur, the patient should notify the health care professional and the need to reduce or stop the insulin administration should be considered.
e se mo no znižanje koncentracije glukoze v krvi pojavlja ve krat, mora bolnik obvestiti zdravnika in pretehtati je treba potrebo o zmanjšanju ali prekinitvi uporabe insulina.
Before travelling between different time zones, the patient should be advised to consult the physician, since this may mean that the patient has to take insulin and meals at different times.
Bolniku je treba svetovati, naj se pred potovanjem med razli nimi asovnimi pasovi posvetuje z zdravnikom, saj takšno potovanje lahko pomeni, da bo moral bolnik uporabiti insulin in uživati obroke ob druga nem asu.
Isolated spontaneous cases are presented as very rare defined as <1/10,000 including isolated reports.
Pogostnosti so opredeljene kot: ob asni (≥ Posamezni spontani primeri so opisani kot zelo redki in opredeljeni kot <1/10.000, vklju no s posameznimi primeri.
• Less exercise than usual.
• Ste manj telesno dejavni kot ponavadi.
If you get a hypo
e doživite hipo
10 ml glass vial (type 1) closed with a bromobutyl/polyisoprene rubber stopper and a protective tamper-proof cap.
10-ml steklena viala (steklo tipa 1), zaprta z brombutil/poliizoprenskim gumijastim zamaškom in zaš itno varnostno zaporko.
The vials that is not being used is to be stored in a refrigerator (2°C - 8°C).
Viale, ki niso v uporabi, shranjujte v hladilniku (med 2 °C in 8 °C).
Consequently, the time-action profile of an insulin preparation is determined solely by its absorption characteristics.
Zato asovni potek delovanja pripravka insulina dolo ajo samo njegove absorpcijske lastnosti.
Velosulin must be protected from excessive heat and sunlight.
Velosulin je treba zaš ititi pred ezmerno toploto in son no svetlobo.
6 weeks when used or stored at room temperature (below 25°C).
6 tednov, e bolnik uporablja zdravilo ali ga hrani pri sobni temperaturi (do 25 °C).
- The active substance is insulin human made by recombinant biotechnology.
- Zdravilna u inkovina je humani insulin, pridobljen z rekombinantno biotehnologijo.
A hypo means your blood sugar level is too low.
Hipa pomeni, da imate prenizek sladkor v krvi.
This process is influenced by several factors (e.g. insulin dosage, injection route and site, thickness of subcutaneous fat, type of diabetes).
Na to dogajanje vpliva ve dejavnikov (npr. odmerjanje insulina, na in in mesto injiciranja, debelina podkožnega maš evja, tip diabetesa).
If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is a symptom of low blood sugar).
Znaki alergije so opisani v e utite, da se pojavlja hipa (hipa je okrajšava za hipoglikemi no reakcijo in pomeni simptome nizkega sladkorja v krvi).
If you inject yourself too often at the same site, fatty tissue under the skin at this site may shrink (lipoatrophy) or thicken (lipohypertrophy).
e insulin prepogosto injicirate na isto mesto, se lahko podkožno maš evje na tem mestu skr i (lipoatrofija) ali zadebeli (lipohipertrofija).
Velosulin is a fast-acting insulin and may be used in combination with certain long-acting insulin products.
Velosulin je hitrodelujo insulin in se lahko uporablja v kombinaciji z nekaterimi dolgodelujo imi insulinskimi zdravili.
When you start taking insulin, water retention may cause swelling around your ankles and other joints.
Ko za nete uporabljati insulin, lahko zastajanje vode povzro i otekline okrog gležnjev in drugih sklepov.
Changes at the injection site (Lipodystrophy).
Spremembe na mestu injiciranja (lipodistrofija).
Severe hypoglycaemia may lead to unconsciousness and/or convulsions and may result in temporary or permanent impairment of brain function or even death.
konvulzije ali oboje in ima lahko za posledico prehodno ali trajno okvaro delovanja možganov ali celo smrt.
The infusion set should be changed every 48 hours using aseptic technique when inserting the infusion set.
Infuzijski komplet je treba zamenjati na 48 ur; pri vstavljanju infuzijskega kompleta je treba uporabljati asepti en postopek.
Pack sizes: 1 and 5 vials x 10 ml and a multipack with 5 x (1 x 10 ml) vials.
Velikost pakiranj: 1 in 5 vial x 10 ml in skupno pakiranje 5 x (1 x 10 ml) vial.
1 ml contains 100 IU of insulin human.
1 ml vsebuje 100 i.e. humanega insulina.
It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice.
Zato je priporo ljivo, da imajo diabeti ni bolniki pri sebi nekaj kock sladkorja, bonbone, piškote ali sadni sok, ki vsebuje sladkor.
Very rare - Anaphylactic reactions
Zelo redki - anafilakti ne reakcije
• if you suddenly feel unwell and you start sweating; start being sick (vomiting); have difficulty in breathing; have a rapid heart beat; feel dizzy; feel like fainting.
• se nenadoma slabo po utite in se za nete znojiti, vam postane slabo (bruhate), imate težave z dihanjem, vam srce hitro bije, ste omoti ni, utite omedlevico.
Like all medicines, Velosulin can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo Velosulin neželene u inke, ki pa se ne pojavijo pri vseh bolnikih.
As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
Kot pri vsakem zdravljenju z insulinom se lahko pojavijo reakcije na mestu injiciranja, med njimi bole ine, srbenje, koprivnica, oteklina in vnetje.
Administration of Velosulin is also possible by subcutaneous or intravenous injection.
Velosulin je mogo e aplicirati tudi v subkutani ali intravenski injekciji.
Hypersensitivity to the active substance or to any of the excipients (see section 6.1).
Preob utljivost za zdravilno u inkovino ali katero od pomožnih snovi (glejte poglavje 6.1).
No profound binding to plasma proteins, except circulating insulin antibodies (if present) has been observed.
Ugotovili niso nobene izrazite vezave na beljakovine v plazmi, razen na krože a protitelesa proti insulinu ( e so prisotna).
• If you exercise more than usual.
• ste telesno bolj dejavni kot ponavadi.
Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/loss of consciousness.
Med simptomi generalizirane preob utljivosti so lahko generaliziran izpuš aj na koži, srbenje, znojenje, gastrointestinalne motnje, angionevroti ni edem, težko dihanje, palpitacije, znižanje krvnega tlaka in omedlevica/izguba zavesti.
Side effects reported very rarely (in less than 1 patient in 10,000)
Neželeni u inki, opisani zelo redko (pri manj kot 1 bolniku na 10.000)
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
V razvrstitvah pogostnosti so neželeni u inki navedeni po padajo i resnosti.
Make sure there is no air left in the syringe: point the needle upwards and push the air out Check you have the right dose
Prepri ajte se, da v brizgi ni ostalo ni zraka: obrnite iglo navzgor in iztisnite zrak.
A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE
A. IZDELOVALEC BIOLOŠKE ZDRAVILNE U INKOVINE IN IMETNIKI DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVORNI ZA SPROŠ ANJE SERIJE
The best places to give yourself an injection are: the front of your waist (abdomen); your buttocks; the front of your thighs or upper arms.
Najprimernejša mesta za injiciranje so: sprednji del trebuha (abdomen), zadnjica in sprednji del stegen ali nadlakti.
Renal or hepatic impairment may reduce insulin requirement.
Okvara ledvic ali jeter lahko zmanjša potrebo po insulinu.
The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Opozorilni znaki hipe se lahko pojavijo nenadoma in lahko obsegajo: hladno znojenje, hladno in bledo kožo, glavobol, hitro bitje srca, ob utek slabosti, hudo lakoto, prehodne spremembe vida, zaspanost, nenavadno utrujenost in šibkost, živ nost ali tresenje, ob utek tesnobe, ob utek zmedenosti, težave s koncentracijo.
It may occur if the insulin dose is too high in relation to the insulin requirement.
Pojavi se lahko, e je odmerek insulina prevelik glede na potrebo po insulinu.
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
Serija: VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT
Use the injection technique advised by your doctor or diabetes nurse
Za injiciranje uporabite postopek, ki vam ga je svetoval zdravnik ali diabetološka sestra.
If you get any of these signs, test your blood sugar level and test your urine for ketones if you can. Then seek medical advice straight away.
e se pojavi kateri od teh znakov, si izmerite sladkor v krvi in dolo ite ketone v urinu, e imate to možnost.
Talk about your insulin needs with your doctor and diabetes nurse.
O svoji potrebi po insulinu se posvetujte z zdravnikom in diabetološko sestro.
Alcohol may intensify and prolong the hypoglycaemic effect of insulin.
Alkohol lahko stopnjuje in podaljša hipoglikemi ni u inek insulina.
Name and address of the manufacturers responsible for batch release
Ime in naslov izdelovalcev, odgovornih za sproš anje serije
If you are allergic (hypersensitive) to this insulin product, metacresol or any of the other ingredients (see 7 Further information).
Ne uporabljajte zdravila Velosulin e ste alergi ni na (preob utljivi za) to insulinsko zdravilo, metakrezol ali kakšno drugo sestavino tega zdravila (glejte poglavje 7.
In type 1 diabetes, untreated hyperglycaemic events eventually lead to diabetic ketoacidosis, which is potentially lethal.
Pri diabetesu tipa 1 nezdravljene hiperglikemije kon no povzro ijo diabeti no ketoacidozo, ki je lahko smrtna.
The amount or timing of insulin, food or exercise may need to be adjusted.
Morda bo treba prilagoditi koli ino ali as dajanja insulina, hrano ali telesno